Alectinib versus crizotinib in ALK‐positive advanced non‐small cell lung cancer and comparison of next‐generation TKIs after crizotinib failure: Real‐world evidence

JOURNAL ARTICLE published December 2022 in Cancer Medicine

Authors: Yurong Wang | Shujing Shen | Peizhu Hu | Di Geng | Ruipan Zheng | Xingya Li